Jessica L. Taylor MD

Assistant Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-7399
Jessica Taylor
Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Biography

Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Chobanian and Avedisian School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed internal medicine residency training at Beth Israel Deaconess Medical Center and Harvard Medical School, where she also served as a Chief Resident. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis.

Her research interests include HIV prevention among people who inject drugs, HIV pre-exposure prophylaxis (PrEP) implementation, low-barrier substance use disorder treatment models, and overdose prevention. She is Co-Director of the Care Continuum Core for the Massachusetts site of the NIDA-funded Healing Communities Study, which aims to reduce fatal opioid overdose by 40%.

Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic and the Medical Director of the Transitional Care Clinic, a bridge clinic co-located with a low-threshold, transitional housing program for people experiencing homelessness. She directs HIV Prevention Programs at BMC. Her educational roles include directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.

Education

Medicine-Internal, MD, Mount Sinai School of Medicine

Psychology, BS, Duke University

Publications

Published on 11/27/2024

De La Hoz A, Pooja A, Kancharla A, Schechter-Perkins EM, Ruiz-Mercado G, Baldwin M, Nunes D, Taylor JL. Characteristics and Outcomes of Direct-Acting Antiviral Experienced Patients with Hepatitis C Undergoing Retreatment at an Essential Hospital in the United States. Open Forum Infect Dis. 2024 Dec; 11(12):ofae704. PMID: 39703790.

Published on 11/4/2024

Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77. PMID: 39497126.

Published on 10/14/2024

De La Hoz A, Gadi N, Lopez CG, Barrera-Godinez A, Miller NS, Bourque DL, Brem C, Ozluk E, Seth G, Kimball S, Taylor JL. Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United States. Open Forum Infect Dis. 2024 Oct; 11(10):ofae587. PMID: 39474451.

Published on 6/26/2024

Laks J, Kim TW, Christine PJ, Evans J, Farrell NM, Kehoe J, Younkin M, Taylor JL. Treating Benzodiazepine Withdrawal in a Bridge Clinic. J Addict Med. 2024 Nov-Dec 01; 18(6):649-656. PMID: 38922639.

Published on 6/11/2024

Taylor C, Loukas V, Muwonge J, Taylor JL, Boyle J. Early Surgical Excision of Necrotic Tissue Following Unintentional Dermal Injection of Extended-Release Buprenorphine. J Addict Med. 2024 Sep-Oct 01; 18(5):605-607. PMID: 38869178.

Published on 6/3/2024

Harris MT, Weinberger E, O'Brien C, Althoff M, Paltrow-Krulwich S, Taylor JL, Judge A, Samet JH, Walley AY, Gunn CM. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs. Addict Sci Clin Pract. 2024 Jun 03; 19(1):47. PMID: 38831359.

Published on 5/12/2024

Taylor JL, Gott J, Weisenthal K, Colicchio P, Dyer S, Komaromy MS. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit. Subst Use Addctn J. 2024 Oct; 45(4):771-776. PMID: 38736211.

Published on 2/16/2024

Lewis NM, Smeltzer RP, Baker TJ, Sahovey AC, Baez J, Hensel E, Poole B, Stewart C, Cogan AG, Bullard M, Taylor JL. Feasibility of paying people who use drugs cash to distribute naloxone within their networks. Harm Reduct J. 2024 Feb 16; 21(1):42. PMID: 38365734.

Published on 2/8/2024

Shahlapour M, Singh S, Christine PJ, Laks J, Evans J, Farrell NM, Khan GK, Taylor JL, Rozansky H. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic. J Addict Med. 2024 May-Jun 01; 18(3):345-347. PMID: 38329815.

Published on 2/1/2024

Stewart J, Ruiz-Mercado G, Sperring H, Pierre CM, Assoumou SA, Taylor JL. Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential Hospital. Open Forum Infect Dis. 2024 Mar; 11(3):ofae056. PMID: 38464490.

View full list of 46 publications.